These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35321980)

  • 1. Two Siblings with Cerebellar Ataxia, Mental Retardation, and Disequilibrium Syndrome 4 and a Novel Variant of ATP8A2.
    Narishige Y; Yaoita H; Shibuya M; Ikeda M; Kodama K; Kawashima A; Okubo Y; Endo W; Inui T; Togashi N; Tanaka S; Kobayashi Y; Onuma A; Takayama J; Tamiya G; Kikuchi A; Kure S; Haginoya K
    Tohoku J Exp Med; 2022 Apr; 256(4):321-326. PubMed ID: 35321980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound Heterozygosity in Cerebellar Ataxia, Mental Retardation, and Disequilibrium Syndrome Type 4.
    Teov B; Janchevska A; Beqiri-Jasari A; Tasic V; Kungulovski G; Gucev Z
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2023 Dec; 44(3):85-90. PubMed ID: 38109455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel homozygous variant in an Iranian pedigree with cerebellar ataxia, mental retardation, and dysequilibrium syndrome type 4.
    Mohamadian M; Ghandil P; Naseri M; Bahrami A; Momen AA
    J Clin Lab Anal; 2020 Nov; 34(11):e23484. PubMed ID: 33079427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further Delineation of the Clinical Phenotype of Cerebellar Ataxia, Mental Retardation, and Disequilibrium Syndrome Type 4.
    Alsahli S; Alrifai MT; Al Tala S; Mutairi FA; Alfadhel M
    J Cent Nerv Syst Dis; 2018; 10():1179573518759682. PubMed ID: 29531481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel missense variant in the ATPase domain of ATP8A2 and review of phenotypic variability of
    Flannery KP; Safwat S; Matsell E; Battula N; Hamed AAA; Mohamed IN; Elseed MA; Koko M; Abubaker R; Abozar F; Elsayed LEO; Bhise V; Molday RS; Salih MA; Yahia A; Manzini MC
    medRxiv; 2024 May; ():. PubMed ID: 38798571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel missense variant in the ATPase domain of ATP8A2 and review of phenotypic variability of ATP8A2-related disorders caused by missense changes.
    Flannery KP; Safwat S; Matsell E; Battula N; Hamed AAA; Mohamed IN; Elseed MA; Koko M; Abubaker R; Abozar F; Elsayed LEO; Bhise V; Molday RS; Salih MA; Yahia A; Manzini MC
    Neurogenetics; 2024 Jul; ():. PubMed ID: 39066872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New ATP8A2 gene mutations associated with a novel syndrome: encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy.
    Martín-Hernández E; Rodríguez-García ME; Camacho A; Matilla-Dueñas A; García-Silva MT; Quijada-Fraile P; Corral-Juan M; Tejada-Palacios P; de Las Heras RS; Arenas J; Martín MA; Martínez-Azorín F
    Neurogenetics; 2016 Oct; 17(4):259-263. PubMed ID: 27679995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recessive mutations in ATP8A2 cause severe hypotonia, cognitive impairment, hyperkinetic movement disorders and progressive optic atrophy.
    McMillan HJ; Telegrafi A; Singleton A; Cho MT; Lelli D; Lynn FC; Griffin J; Asamoah A; Rinne T; Erasmus CE; Koolen DA; Haaxma CA; Keren B; Doummar D; Mignot C; Thompson I; Velsher L; Dehghani M; Vahidi Mehrjardi MY; Maroofian R; Tchan M; Simons C; Christodoulou J; Martín-Hernández E; Guillen Sacoto MJ; Henderson LB; McLaughlin H; Molday LL; Molday RS; Yoon G
    Orphanet J Rare Dis; 2018 May; 13(1):86. PubMed ID: 30012219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion.
    Onat OE; Gulsuner S; Bilguvar K; Nazli Basak A; Topaloglu H; Tan M; Tan U; Gunel M; Ozcelik T
    Eur J Hum Genet; 2013 Mar; 21(3):281-5. PubMed ID: 22892528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP8A2-related disorders as recessive cerebellar ataxia.
    Guissart C; Harrison AN; Benkirane M; Oncel I; Arslan EA; Chassevent AK; Baraῆano K; Larrieu L; Iascone M; Tenconi R; Claustres M; Eroglu-Ertugrul N; Calvas P; Topaloglu H; Molday RS; Koenig M
    J Neurol; 2020 Jan; 267(1):203-213. PubMed ID: 31612321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and in silico analysis of ATP8A2 and other P4-ATPase variants associated with human genetic diseases.
    Matsell E; Andersen JP; Molday RS
    Dis Model Mech; 2024 Jun; 17(6):. PubMed ID: 38436085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital ataxia due to novel variant in ATP8A2.
    Damásio J; Santos D; Morais S; Brás J; Guerreiro R; Sardoeira A; Cavaco S; Carrilho I; Barbot C; Barros J; Sequeiros J
    Clin Genet; 2021 Jul; 100(1):79-83. PubMed ID: 33682124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biallelic loss-of-function variants in DOCK3 cause muscle hypotonia, ataxia, and intellectual disability.
    Helbig KL; Mroske C; Moorthy D; Sajan SA; Velinov M
    Clin Genet; 2017 Oct; 92(4):430-433. PubMed ID: 28195318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid flippase ATP8A2 is required for normal visual and auditory function and photoreceptor and spiral ganglion cell survival.
    Coleman JA; Zhu X; Djajadi HR; Molday LL; Smith RS; Libby RT; John SW; Molday RS
    J Cell Sci; 2014 Mar; 127(Pt 5):1138-49. PubMed ID: 24413176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome sequencing reveals a novel CWF19L1 mutation associated with intellectual disability and cerebellar atrophy.
    Evers C; Kaufmann L; Seitz A; Paramasivam N; Granzow M; Karch S; Fischer C; Hinderhofer K; Gdynia G; Elsässer M; Pinkert S; Schlesner M; Bartram CR; Moog U
    Am J Med Genet A; 2016 Jun; 170(6):1502-9. PubMed ID: 27016154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylserine flipping by the P4-ATPase ATP8A2 is electrogenic.
    Tadini-Buoninsegni F; Mikkelsen SA; Mogensen LS; Molday RS; Andersen JP
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16332-16337. PubMed ID: 31371510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel variants in critical domains of ATP8A2 and expansion of clinical spectrum.
    Heidari E; Harrison AN; Jafarinia E; Tavasoli AR; Almadani N; Molday RS; Garshasbi M
    Hum Mutat; 2021 May; 42(5):491-497. PubMed ID: 33565221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel pathogenic variant in the 3' end of the AGTPBP1 gene gives rise to neurodegeneration without cerebellar atrophy: an expansion of the disease phenotype?
    Türay S; Eröz R; Başak AN
    Neurogenetics; 2021 May; 22(2):127-132. PubMed ID: 33909173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy.
    Reinson K; Õiglane-Shlik E; Talvik I; Vaher U; Õunapuu A; Ennok M; Teek R; Pajusalu S; Murumets Ü; Tomberg T; Puusepp S; Piirsoo A; Reimand T; Õunap K
    Am J Med Genet A; 2016 Aug; 170(8):2173-6. PubMed ID: 27250579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and functional characterization of missense mutations in ATP8A2 linked to severe neurological disorders.
    Choi H; Andersen JP; Molday RS
    Hum Mutat; 2019 Dec; 40(12):2353-2364. PubMed ID: 31397519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.